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The objective of this study was to investigate the antioxidant capacity and anti-hyperglycemic activity 
of aqueous macerate extracts of Euphorbia hirta L., in the treatment of hypertension associated with d abetes. 
The research focused on the aqueous maceration of the aerial part or totum. The search and evaluation of the 
antioxidant activity was done according to the method of Blois based on the reduction of 2,2-diphenyl-1-
picrylhydrazyl (DPPH). The search for antihyperglycaemic activity was performed on rats having received a 
glucose overdose. This activity was compared to those f glyburide and metformin. The totum showed a 
percentage inhibition of 63.66 ± 0.54% for 1 mg/mL of extract and an IC50 of 0.031 ± 0.001 µg/mL .A 200 
mg/kg extract has shown a very good antihyperglycaemic activity; while on normal blood sugar, the activity 
was not important compared with glyburide and metformin. These results show the presence of antioxidant and 
normoglycaemic substances in aqueous macerated of Euphorbia hirta L. 
© 2013 International Formulae Group. All rights reserved. 
 




The use of medicinal plants for the 
treatment of metabolic diseases is gaining 
ground more and more in the world (Mamun-
Or-Rashid et al., 2013). Diabetes and 
hypertension are frequently two associated 
pathologies in patients (Dembele et al., 2000). 
This association is a serious economic 
problem, lowers patient comfort and reduces 
the vital prognosis of the patient. 
The World Health Organization has 
recommended and encouraged research and 
use of medicinal plants especially in countries 
where access to modern medicine and 
conventional treatment is difficult. Also, these 
drugs of modern medicine may have 
significant side effects. Thus, the search for 
medicinal plants, effective on diabetes as well 
as on hypertension, has been undertaken 
(N’Guessan, 2008; Tra Bi et al., 2008). 
Among others, they are: Allium sativum L. 





(Liliaceae), Cassia occidentalis L. 
(Caesalpiniaceae) Chrysophyllum cainito L. 
(Sapotaceae), Clerodendrum inerme (L.) 
Gaertn. (Verbenaceae), Crescentia cujete L. 
(Bignoniaceae), Euphorbia hirta (L) 
(Euphorbiaceae), L. Jatropha curcas 
(Euphorbiaceae) Jatropha gossypiifolia L. 
(Euphorbiaceae) Mangifera indica L. 
(Anacardiaceae) (N’Guessan, 2008; Tra Bi et 
al., 2008). Euphorbia hirta L. has been 
selected because of its anti-hypertensive 
activity already proven (Huang et al., 2012; 
Johnson et al., 1999). It is an annual plant, 
abundant on the waves along the roads and 
open grassland soils, found in India and 
tropical Australia and widespread in tropical 
and subtropical countries (Adjanohoun et al., 
1986). Traditionally, this plant species is used 
in the treatment of gastrointestinal disorders, 
bronchial and respiratory diseases, kidney 
stones, diabetes, conjunctivitis (N’Guessan, 
2008; Tra Bi et al., 2008). Many properties of 
the plant have already been demonstrated, 
among others, antipyretic, analgesic, 
bactericidal activity (Lanhers et al., 2005; 
Mamun-Or-Rashid, 2013). 
This study aims at evaluating the 
antioxidant capacity and the anti-
hyperglycemic activity of aqueous macerate 
extracts in the treatment of hypertension 
associated with diabetes. 
 
MATERIALS AND METHODS 
Chemicals and equipment  
Glyburide and metformin were used as 
reference substances, 2,2-diphenyl-1-
picrylhydrazyl (DPPH) was used for research 
and evaluation of antioxidant compounds. 
Blood sugar was measured using a glucometer 
(Accu-Chek® Active, Roche, Germany). 
 
Animal material  
Healthy albino mice (male and female) 
weighing 30-60 ages between 8 and 10 weeks 
and adult rats of both sexes, of the race Wistar 
aged from 4 to 12 weeks. The animals were 
acclimated for 2 weeks before 
experimentation. All animals were maintained 
under standard environmental conditions. The 
room temperature was 22±2 °C and relative 
humidity was 45-55%. Each cycle of light and 
darkness lasted 12 hours. The animals had 
access to feeds ad libitum to tap water and 
adapted feeds for rodents that is pellets. 
 
Plant material  
It consists of the aerial part (stem and 
leaves) of Euphorbia hirta L., collected in 
February 2012 in Adzopé, a locality in the 
Agnéby region north of Abidjan (Côte 
d'Ivoire). The identification was made in the 
Department of Botany at the University of 
Felix Houphouët Boigny, Abidjan. A 
specimen is deposited in the Herbarium of the 
National Centre of Floristic in the University 
under No 01. FY February 2012. Plants 
harvested were washed with water and then 
dried in the shade on trays at room 
temperature. 
 
Preparation of extracts 
 The medicinal plant was spray dried 
coarsely. 100 g were soaked in 1000 mL of 
distilled water for 24 hours without agitation. 
The filtrate, corresponding to the mode of use 
in the traditional medicine, was used at 
different doses for research of anti-
hyperglycaemic activity. Two aliquots were 
taken. One was concentrated with a rotary 
evaporator and then lyophilized. The other 
with different solvents of increasing polarity 
successively (petroleum ether (EP), 
chloroform (C), ethyl acetate (AE) and 
butanol (B)). All extracts were dried, and used 









Research and evaluation of the anti-oxidant 
activity by DPPH 
 The ability of the extract to scavenge 
DPPH radical was first sought by TLC as 
described for the first time by Blois (1958) 
using the DPPH (Takao et al., 1994). Then, 
this ability was assessed using the method of 
Velazquez et al. (2003). 200 µL of a freshly 
prepared methanolic solution of DPPH (20 mg 
L-1) was mixed with 100 µl of extract solution 
(7 dilutions to ½ from 1 mg mL-1). After 15 
min of incubation in the dark at room 
temperature, absorbance was read at 517 nm 
against a negative control (100 µl of methanol 
and 200 µl of DPPH) and a blank sample (100 
µl of extract and 200 µI of DPPH). All the 
determinations were performed in triplicate. 
DPPH radical inhibition percentage was 
calculated according to the formula of 
Miliauskas et al. (2004). 
 
Inhibition (%) = [(AB - AA) / AB] * 100  
 
Where AB is the blank absorbance and AA, the 
sample absorbance (test extract solution), IC50
value (50% inhibitory concentration of DPPH 
radical) was obtained by graphic 
determination. A Lower IC50 value indicates 
greater antioxidant activity. 
 
Evaluation of the hypoglycemic and anti-
hyperglycemic activity 
 The evaluation of the totum needs 66 
adult rats of both sexes weighing between 100 
and 200 grams. They were fasted for 12 hours 
before testing begins with free access to 
water. The rats were divided into 11 groups of 
6, homogeneous weights. The Batches were 
made as follows:  
Batch 1: normoglycaemic rats treated with 
water; 
Batch 2: rats made hyperglycaemic treated 
with water; 
Batch 3: rats made hyperglycaemic treated 
with Glyburide 5 mg/kg; 
Batch 4: rats made hyperglycaemic treated 
with metformin 500 mg/kg; 
Batch 5: rats made hyperglycaemic treated 
with the extract extemporaneous to 1000 
mg/kg; 
Batch 6: rats made hyperglycaemic treated 
with dry extract 100 mg/kg; 
Batch 7: rats made hyperglycaemic treated 
with dry extract 200 mg/kg; 
Batch 8: normoglycaemic rats treated with the 
extract extemporaneous 1 g/kg; 
Batch 9: normoglycaemic rats treated with dry 
extract 100 mg/kg; 
Batch 10: normoglycaemic rats treated with 
dry extract 200 mg/kg; 
Batch 11: normoglycaemic rats treated with 
dry extract 1000 mg/kg. 
 
Testing for anti-hyperglycaemic activity  
 An overload of glucose at 3g/kg of 
body weight was administered to rats in 
fasting state for 18 hours to cause 
hyperglycaemia (Kwashié et al., 1998; 
Gharras et al., 1999; Lukens et al., 1948). The 
rats that have hyperglycaemia (HG) greater 
than or equal to 0.5 g L-1 compared to the 
basic glucose level were selected. 
Immediately after, batches 2 to 7 were treated 
by gavage with water extract or reference 
antidiabetic. The administration volume is 10 
mL kg-1 weight. Glucose (Gt) level of each 
animal was measured every 30 minutes (t) for 
90 minutes from a drop of blood from the tail 
vein applied to an Accu-Chek® Active. Anti- 
hyperglycaemic activity was expressed as 
percentage of inhibition (Inh) of previously 
induced hyperglycemia compared to 
hyperglycemic control sample group (HG) 
and by following the formula:  
Inh (%) = (HG-Gt) * 100) / HG. 
 
Testing for hypoglycaemic activity 
 The rats in this study did not receive 
glucose overdose. After fasting, they received 
different doses of extract by gavage. Glucose 





(Gt) was measured under the same conditions 
as above. The hypoglycaemic activity was 
expressed as a percentage decrease (D) of 
basic blood sugar (GB) over time compared to 
normoglycaemic control group according to 
the following formula:  
D = (GB-Gt) * 100 / GB. 
 
Statistical analysis  
 The data obtained for the study of anti-
hyperglycemic and hypoglycemic activities 
are expressed as mean ± standard deviation. 
The comparison between different groups was 
made by analysis of variance (ANOVA), and 
the Student t-test was used to separate the 
means. A p value ˂ 0.01 is considered highly 
significant and a p value ˂ 0.05 is significant. 
 
RESULTS 
Research and evaluation of the antioxidant 
constituents  
The yellow spots on purple background 
revealed by DPPH were abundant (Figure 1). 
The totum was well separated by the 
developing petroleum ether: ethyl acetate 
(1:2) and isolating pure compounds. 
Chromatogram 2 shows the presence of 
abundant antioxidants polar compounds, 
dragged along the length of migration. A 
small discontinuity is observed. This is due to 
the presence of the compound not having an 
antioxidant activity. The chromatogram 4 
shows three spots of the ethyl acetate fraction 
of which is one dominant. 
The aqueous maceration of the aerial 
part (stem and leaf) of Euphorbia hirta L. 
showed an ability to scavenge DPPH of 63.66 
± 0.54% at a concentration of 1 mg mL-1. The 
evaluation of the antioxidant activity gave a 
mean inhibitory concentration IC₅₀ = 0.031 ± 
0.001 µg mL-1 (Figures 2-4). 
 
 
Effect on hyperglycemia caused by oral 
glucose 
Inhibition of hyperglycemia was 
significant (p < 0.05) at dose of 100 and 1000 
mg/kg body weight and highly significant at 
200 mg/kg (p < 0.01). 
Comparing the inhibition dose at 100 to 
that of the 1000 mg/kg, the difference was 
highly significant at 30 min (-16.48% and -
14.63%) and 60 min (-46.44% and -28.37%) 
(p < 0.01), but after 1 hr 30, inhibition of 
hyperglycemia was attenuated (p < 0.05) (-
53.77% and -31.94%). This very significant 
difference was also observed between doses 
of 200 and 1000 mg/kg bw on the entire 
duration of the experiment (-28.46% -49.60% 
and -53.17% by contributing to -14 63% -
28.37% -31.94%). 
However, between doses of 100 and 
200 mg/kg a significant difference was 
observed at 30 min after administration of 
totum. Thereafter, there was no significant 
difference between the effects exerted by the 
two doses.  
The intensity of the decrease in blood 
glucose induced by the extract at 200 mg / kg 
was comparable to that induced by glyburide 
and metformin (Figure 5) without causing 
hypoglycaemia. Indeed, glucose level of the 
batch treated with the extract at 200 mg kg-1 is 
around the value of the basic glucose level 
and seems to evolve between 60 and 90 
minutes (Figure 5) while glyburide and 
metformin exercise hypoglycemic effect. 
 
Effect on normal blood sugar  
On the basis of normal sugar level, 
extracts have not led to a significant decline. 
All changes remained around the basic sugar 
level. The percentage decreases were less than 
10%. Indeed, they were for the samples at 60 
and 90 min, 1% and -6% for the 100 mg/kg -
6% and -8% for the dose of 200 mg/kg and -
2%and -7% for the dose of 1000 mg kg-1 
(Figure 6). 























Figure 1: Chromatograms of the antioxidant activity of Euphorbia hirta. 
Legend of Figure 1 : 
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Figure 2: Inhibition curve of DPPH test 1 totum of Euphorbia hirta. 
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Figure 3: Inhibition curve of DPPH test 2 totum of Euphorbia hirta. 
 
 
Figure 4: Inhibition curve of DPPH test 3 totum of Euphorbia hirta. 






Figure 5: Glycaemia variation curve for hyperglycaemic rats treated with herbal medicine at 100 
mg kg-1, 200 mg kg-1 1000 mg kg-1, Metformin 500mg kg-1 and Glyburide 5mg kg-1.  
Mean ± SEM, n =6, p* < 0.05; p**<0,01.  
Batch 1: hyperglycaemic rats treated with water; Batch 3: hyperglycaemic rats treated with Glyburide 5 mg/kg; 
Batch 4: hyperglycaemic rats treated with metformin 500 mg/kg; Batch 5: hyperglycaemic rats treated with extract 
extemporaneous at 1000 mg/kg; Batch 6: hyperglycaemic rats treated with dry extract 100 mg/kg; Batch 7: hyperglycaemic 
rats treated with dry extract 200 mg/kg; 
 
 
Figure 6: Glycaemia variation curve for normal glycaemic rats treated with herbal medicine at 100 
mg kg-1, 200 mg kg-1 and 1000 mg kg-1. 
Batch 1: normoglycaemic rats treated with water; Batch 9: normoglycaemic rats treated with dry extract 100 mg kg-1; 
Batch 10: normoglycaemic rats treated with dry extract 200 mg kg-1; Batch 10: normoglycaemic rats treated with dry extract 
1000 mg kg-1. 






This study showed the effect of 
aqueous macerated Euphorbia hirta L. 
collected in Côte d'Ivoire on induced 
hyperglycemia and normal blood sugar of 
non-diabetic Wistar rats. Diabetes was treated 
with different herbs over a long period. The 
extracts of these plants have improved 
diabetes control and reduced side effects 
associated with drugs or synthetic hemi-
synthesis (Bolkent et al., 2000; Aybar et al., 
2001). Therefore, the search for more 
effective medicinal plants has become an 
important issue. The antioxidant compounds 
are known for their biological activities 
including multidirectional anti-diabetic 
(Brahmachari, 2008; Brahmachari et al., 
2009) efficiency. Thus, a study of the aqueous 
extract of E. hirta L. on oral glucose tolerance 
in rats has shown a good reduction without 
causing hypoglycemia. Our results are in 
agreement with that of Kumar et al. (2010) 
who also found a highly significant anti-
diabetic activity at doses of 250 and 500 mg/ 
kg body weight in rats made diabetic. This 
activity could have plenty of supporting 
antioxidant compounds present in the aqueous 
totum (Singh et al., 2013). Reduction in its 
antioxidant capacity was identified by thin-
layer chromatography with a yellow color on 
a purple background (Onawumi et al., 2012). 
The antioxidant activity may be related to the 
presence of polar compounds with 
polyphenols (N’Guessan et al., 2011). The 
presence in the totum was remarkable 
compared to the ethyl acetate extract. 
However, the ethyl acetate extract is a 
majority antioxidant compounds with better 
reducing capacity (Tibiri et al., 2010). The 
anti-oxidant activity would be increased by 
less polar and non-polar substances 
(Jagadeesan et al., 2011; Tiwari et al., 2010). 
Measuring the absorbance of DPPH at 517 nm 
in the presence of aqueous extract of E. hirta 
L. showed a greater reduction of DPPH due to 
the important work done by trapping the 
extracts (Bakasso et al., 2008). Inhibiting 
concentration IC50, which is the amount of 
compound required to decrease antioxidant 
initial DPPH concentration of 50% was 
determined graphically. The importance of 
antioxidant activity results in a low value of 
the IC50. The aqueous extract of E hirta shows 
a low value of the IC50. This activity confirms 
that of Basma et al. (2011). All this time, IC50 
obtained with the aqueous extract is lower 
compared to the methanol extract of Basma et 
al. (2011). This difference could be due to the 
presence of compound extracted by water, 
such as mucilage, which precipitates in the 
presence of alcohol (Moussaid et al., 2012). 
 
Conclusion 
These results support the traditional use 
of the aqueous extract of E. hirta L. The totum 
may decrease hyperglycemia without risk of 
hypoglycemia. Thus, it can provide abundant 
antioxidant compound to treat or mitigate any 
disease related to a metabolic disorder which 
itself is linked to oxidative stress responsible 
for various metabolic diseases including 
hypertension with which it is often associated.  
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